Penumbra Revenue 2014-2024 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending June 30, 2024 was $0.299B, a 14.49% increase year-over-year.
- Penumbra revenue for the twelve months ending June 30, 2024 was $1.134B, a 20.89% increase year-over-year.
- Penumbra annual revenue for 2023 was $1.059B, a 24.95% increase from 2022.
- Penumbra annual revenue for 2022 was $0.847B, a 13.32% increase from 2021.
- Penumbra annual revenue for 2021 was $0.748B, a 33.4% increase from 2020.
| Penumbra Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,059 |
| 2022 | $847 |
| 2021 | $748 |
| 2020 | $560 |
| 2019 | $547 |
| 2018 | $445 |
| 2017 | $334 |
| 2016 | $263 |
| 2015 | $186 |
| 2014 | $126 |
| 2013 | $89 |
| Penumbra Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $299 |
| 2024-03-31 | $279 |
| 2023-12-31 | $285 |
| 2023-09-30 | $271 |
| 2023-06-30 | $261 |
| 2023-03-31 | $241 |
| 2022-12-31 | $221 |
| 2022-09-30 | $214 |
| 2022-06-30 | $208 |
| 2022-03-31 | $204 |
| 2021-12-31 | $204 |
| 2021-09-30 | $190 |
| 2021-06-30 | $184 |
| 2021-03-31 | $169 |
| 2020-12-31 | $167 |
| 2020-09-30 | $151 |
| 2020-06-30 | $105 |
| 2020-03-31 | $137 |
| 2019-12-31 | $145 |
| 2019-09-30 | $140 |
| 2019-06-30 | $134 |
| 2019-03-31 | $128 |
| 2018-12-31 | $121 |
| 2018-09-30 | $112 |
| 2018-06-30 | $110 |
| 2018-03-31 | $103 |
| 2017-12-31 | $96 |
| 2017-09-30 | $84 |
| 2017-06-30 | $81 |
| 2017-03-31 | $73 |
| 2016-12-31 | $73 |
| 2016-09-30 | $67 |
| 2016-06-30 | $65 |
| 2016-03-31 | $58 |
| 2015-12-31 | $54 |
| 2015-09-30 | $50 |
| 2015-06-30 | $42 |
| 2015-03-31 | $39 |
| 2014-12-31 | |
| 2014-09-30 | $32 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.893B | $1.059B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.021B | 27.33 |
| Intuitive Surgical (ISRG) | United States | $172.269B | 97.54 |
| Alcon (ALC) | Switzerland | $47.692B | 33.57 |
| IQVIA Holdings (IQV) | United States | $41.794B | 23.68 |
| Edwards Lifesciences (EW) | United States | $41.042B | 26.31 |
| IDEXX Laboratories (IDXX) | United States | $39.200B | 47.16 |
| DexCom (DXCM) | United States | $27.734B | 39.55 |
| STERIS (STE) | Ireland | $22.376B | 26.11 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.049B | 0.00 |
| Waters (WAT) | United States | $21.250B | 31.68 |
| Hologic (HOLX) | United States | $18.538B | 20.15 |
| Sysmex ADR (SSMXY) | Japan | $12.254B | 38.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.502B | 12.89 |
| Teleflex (TFX) | United States | $11.121B | 17.29 |
| Globus Medical (GMED) | United States | $9.556B | 26.73 |
| Masimo (MASI) | United States | $7.481B | 40.06 |
| Glaukos (GKOS) | United States | $6.973B | 0.00 |
| TransMedics (TMDX) | United States | $4.510B | 193.13 |
| Integer Holdings (ITGR) | United States | $4.334B | 25.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.724B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.852B | 16.73 |
| Veracyte (VCYT) | United States | $2.613B | 162.00 |
| Elekta AB (EKTAY) | Sweden | $2.595B | 21.14 |
| Inari Medical (NARI) | United States | $2.436B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.427B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.246B | 13.98 |
| RxSight (RXST) | United States | $1.857B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.492B | 6.80 |
| Artivion (AORT) | United States | $1.086B | 99.69 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.037B | 18.50 |
| OPKO Health (OPK) | United States | $1.018B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.723B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.683B | 17.24 |
| AxoGen (AXGN) | United States | $0.645B | 0.00 |
| IRadimed (IRMD) | United States | $0.639B | 34.53 |
| OrthoPediatrics (KIDS) | United States | $0.596B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.595B | 0.00 |
| SiBone (SIBN) | United States | $0.547B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.540B | 0.00 |
| Paragon 28 (FNA) | United States | $0.478B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 10.26 |
| Treace Medical Concepts (TMCI) | United States | $0.327B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.320B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.289B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.260B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.231B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| NeuroPace (NPCE) | United States | $0.193B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.192B | 13.46 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.180B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.125B | 0.00 |
| 908 Devices (MASS) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.109B | 16.15 |
| EDAP TMS S.A (EDAP) | France | $0.097B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.056B | 0.00 |
| Envoy Medical (COCH) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.042B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.038B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.027B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |